Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer
Completed · Phase 2 · Has a placebo group
Conditions studied: Breast Cancer
In brief
This was an open label, multi-center protocol for U.S. patients enrolled in the study of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative, high risk early breast cancer
Key facts
- Study ID
- NCT03078751
- Run by
- Novartis Pharmaceuticals
- People needed
- 54
- Starts
- 2017-06-20
- Expected to finish
- 2020-03-09
- Last updated by the study team
- 2021-10-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arizona Oncology Associates PC- HAL — Tucson, Arizona, United States
- Highlands Oncology Group — Fayetteville, Arkansas, United States
- CBCC Global Research — Bakersfield, California, United States
- University of California - Los Angeles — Los Angeles, California, United States
- Ventura County Hematology and Oncology — Oxnard, California, United States
- TRIO - Torrance Health Association — Redondo Beach, California, United States
- Innovative Clinical Research Institute — Whittier, California, United States
- Rocky Mountain Cancer Centers Regulatory — Denver, Colorado, United States
- Eastern Connecticut Hematology and Oncology Associates — Norwich, Connecticut, United States
- Florida Cancer Specialists South Region — Fort Myers, Florida, United States
- Memorial Regional Hospital — Hollywood, Florida, United States
- Hematology Oncology Associates of the Treasure Coast — Port Saint Lucie, Florida, United States
- Florida Cancer Specialists - North Florida Cancer Specialist N — St. Petersburg, Florida, United States
- Northside Hospital Central Research Dept. — Atlanta, Georgia, United States
- Summit Cancer Care, PC — Savannah, Georgia, United States
- Health Midwest Ventures Group, Inc d/b/a HCA MidAmerica Div. — Leawood, Kansas, United States
- Maryland Oncology Hematology P A — Silver Spring, Maryland, United States
- Saint Luke's Hospital of Kansas City — Kansas City, Missouri, United States
- Saint Barnabas Medical Center 2nd Floor East Wing — Livingston, New Jersey, United States
- Pro Health Care Associates — New Hyde Park, New York, United States
- The Presbyterian Hospital — Charlotte, North Carolina, United States
- Tennessee Oncology, PLLC — Chattanooga, Tennessee, United States
- The West Clinic — Germantown, Tennessee, United States
- SCRI - Tennessee Oncology — Nashville, Tennessee, United States
- Baylor Charles A. Sammons Cancer Center — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.